Zoetis Cash & Equivalents decreased by 20.8% to $1.94B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.9%, from $1.78B to $1.94B. Over 5 years (FY 2020 to FY 2025), Cash & Equivalents shows a downward trend with a -7.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase signals improved liquidity and financial flexibility, while a decrease may indicate heavy capital expenditure, debt repayment, or aggressive share buybacks.
Represents the most liquid assets on the balance sheet, including physical currency and short-term investments with matu...
Large-cap technology peers often maintain high cash balances to fund rapid innovation and offset the cyclical nature of consumer electronics.
cash_and_equivalents| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.66B | $3.27B | $3.49B | $3.14B | $2.65B | $2.51B | $3.58B | $2.11B | $1.72B | $1.75B | $2.04B | $1.98B | $1.57B | $1.71B | $2.11B | $1.78B | $1.44B | $2.08B | $2.45B | $1.94B |
| QoQ Change | — | -10.5% | +6.4% | -10.0% | -15.4% | -5.5% | +42.8% | -41.1% | -18.6% | +2.2% | +16.4% | -3.2% | -20.3% | +8.9% | +23.3% | -15.7% | -19.5% | +45.2% | +17.6% | -20.8% |
| YoY Change | — | — | — | — | -27.5% | -23.4% | +2.8% | -32.7% | -35.3% | -30.0% | -43.0% | -6.4% | -8.3% | -2.3% | +3.6% | -9.8% | -8.8% | +21.6% | +15.9% | +8.9% |